膀胱过度活动症 - Suppr

Suppr

超能文献

The overactive bladder.

作者信息

Wyndaele J J

机构信息

Department of Urology, Faculty of Medical and Pharmaceutical Sciences, University Antwerpen, Antwerpen, Belgium.

出版信息

BJU Int. 2001 Jul;88(2):135-40. doi: 10.1046/j.1464-410x.2001.02296.x.

DOI:10.1046/j.1464-410x.2001.02296.x

PMID:11446871

Abstract

摘要

相似文献

The overactive bladder.

BJU Int. 2001 Jul;88(2):135-40. doi: 10.1046/j.1464-410x.2001.02296.x.

Case for pharmacotherapy development for underactive bladder.

Urology. 2008 Nov;72(5):966-7. doi: 10.1016/j.urology.2008.04.041. Epub 2008 Sep 6.

Overactive bladder.

Best Pract Res Clin Obstet Gynaecol. 2005 Dec;19(6):829-41. doi: 10.1016/j.bpobgyn.2005.08.002. Epub 2005 Sep 19.

Underactive Bladder in Older Adults.

Clin Geriatr Med. 2015 Nov;31(4):523-33. doi: 10.1016/j.cger.2015.06.002. Epub 2015 Jul 26.

Advanced therapeutic directions to treat the underactive bladder.

Int Urol Nephrol. 2014 Sep;46 Suppl 1:S35-44. doi: 10.1007/s11255-014-0809-8. Epub 2014 Sep 20.

Behavioural approaches are helpful in overactive bladder.

BMJ. 2003 Aug 2;327(7409):291. doi: 10.1136/bmj.327.7409.291.

Medical therapy for the overactive bladder in the elderly.

Age Ageing. 2002 Jul;31(4):241-6. doi: 10.1093/ageing/31.4.241.

Prognostic factors for successful percutaneous tibial nerve stimulation.

Eur Urol. 2006 Feb;49(2):360-5. doi: 10.1016/j.eururo.2005.10.019. Epub 2005 Dec 6.

Improving conservative treatment of overactive bladder and urge incontinence--1 small step at a time.

J Urol. 2001 Jul;166(1):150-1.

[Henoch-Schönlein purpura resulting in an obstructive bladder mass].

Aktuelle Urol. 2013 Nov;44(6):462-3. doi: 10.1055/s-0033-1348244. Epub 2013 Jul 3.

引用本文的文献

Overactive bladder, differential diagnosis, and clinical utility of fesoterodine.

Int J Gen Med. 2012;5:943-51. doi: 10.2147/IJGM.S24236. Epub 2012 Nov 12.

Pathophysiology of overactive bladder.

Int Urogynecol J. 2012 Aug;23(8):975-82. doi: 10.1007/s00192-012-1682-6. Epub 2012 Feb 7.

Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder.

World J Urol. 2005 Sep;23(4):248-52. doi: 10.1007/s00345-005-0507-3. Epub 2005 Nov 8.

Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):71-8. doi: 10.1007/s00210-005-1084-0. Epub 2005 Jul 30.

Extracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Mar;369(3):281-6. doi: 10.1007/s00210-004-0869-x. Epub 2004 Feb 13.

Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors?

Naunyn Schmiedebergs Arch Pharmacol. 2003 May;367(5):524-31. doi: 10.1007/s00210-003-0713-8. Epub 2003 Mar 28.

Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle.

Br J Pharmacol. 2003 Mar;138(5):757-66. doi: 10.1038/sj.bjp.0705109.

A benefit-risk assessment of extended-release oxybutynin.

Drug Saf. 2002;25(12):867-76. doi: 10.2165/00002018-200225120-00004.

M(3) muscarinic receptors mediate contraction of human urinary bladder.

Br J Pharmacol. 2002 Jul;136(5):641-3. doi: 10.1038/sj.bjp.0704781.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The overactive bladder.

BJU Int. 2001 Jul;88(2):135-40. doi: 10.1046/j.1464-410x.2001.02296.x.

Case for pharmacotherapy development for underactive bladder.

Urology. 2008 Nov;72(5):966-7. doi: 10.1016/j.urology.2008.04.041. Epub 2008 Sep 6.

Overactive bladder.

Best Pract Res Clin Obstet Gynaecol. 2005 Dec;19(6):829-41. doi: 10.1016/j.bpobgyn.2005.08.002. Epub 2005 Sep 19.

Underactive Bladder in Older Adults.

Clin Geriatr Med. 2015 Nov;31(4):523-33. doi: 10.1016/j.cger.2015.06.002. Epub 2015 Jul 26.

Advanced therapeutic directions to treat the underactive bladder.

Int Urol Nephrol. 2014 Sep;46 Suppl 1:S35-44. doi: 10.1007/s11255-014-0809-8. Epub 2014 Sep 20.

Behavioural approaches are helpful in overactive bladder.

BMJ. 2003 Aug 2;327(7409):291. doi: 10.1136/bmj.327.7409.291.

Medical therapy for the overactive bladder in the elderly.

Age Ageing. 2002 Jul;31(4):241-6. doi: 10.1093/ageing/31.4.241.

Prognostic factors for successful percutaneous tibial nerve stimulation.

Eur Urol. 2006 Feb;49(2):360-5. doi: 10.1016/j.eururo.2005.10.019. Epub 2005 Dec 6.

Improving conservative treatment of overactive bladder and urge incontinence--1 small step at a time.

J Urol. 2001 Jul;166(1):150-1.

[Henoch-Schönlein purpura resulting in an obstructive bladder mass].

Aktuelle Urol. 2013 Nov;44(6):462-3. doi: 10.1055/s-0033-1348244. Epub 2013 Jul 3.

引用本文的文献

Overactive bladder, differential diagnosis, and clinical utility of fesoterodine.

Int J Gen Med. 2012;5:943-51. doi: 10.2147/IJGM.S24236. Epub 2012 Nov 12.

Pathophysiology of overactive bladder.

Int Urogynecol J. 2012 Aug;23(8):975-82. doi: 10.1007/s00192-012-1682-6. Epub 2012 Feb 7.

Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder.

World J Urol. 2005 Sep;23(4):248-52. doi: 10.1007/s00345-005-0507-3. Epub 2005 Nov 8.

Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):71-8. doi: 10.1007/s00210-005-1084-0. Epub 2005 Jul 30.

Extracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Mar;369(3):281-6. doi: 10.1007/s00210-004-0869-x. Epub 2004 Feb 13.

Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors?

Naunyn Schmiedebergs Arch Pharmacol. 2003 May;367(5):524-31. doi: 10.1007/s00210-003-0713-8. Epub 2003 Mar 28.

Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle.

Br J Pharmacol. 2003 Mar;138(5):757-66. doi: 10.1038/sj.bjp.0705109.

A benefit-risk assessment of extended-release oxybutynin.

Drug Saf. 2002;25(12):867-76. doi: 10.2165/00002018-200225120-00004.

M(3) muscarinic receptors mediate contraction of human urinary bladder.

Br J Pharmacol. 2002 Jul;136(5):641-3. doi: 10.1038/sj.bjp.0704781.